Cell surface molecules and their prognostic values in assessing colorectal carcinomas

被引:59
作者
Haier, J [1 ]
Nasralla, M [1 ]
Nicolson, GL [1 ]
机构
[1] Inst Mol Med, Huntington Beach, CA 92649 USA
关键词
D O I
10.1097/00000658-200001000-00003
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective Carcinomas of the colon and rectum are the third leading cause of cancer-related deaths. Although advances in the surgical treatment of primary colorectal cancers have lead to improvements in patient survival at early tumor stages, treatment of more progressive cancers has not resulted in dramatic improvements in patient survival. However, the selection of patient subgroups based on their prognosis and other characteristics could result in improved outcomes from adjuvant therapies in patients with Dukes B and C carcinomas. Methods The authors reviewed the available data on the value of cell surface molecules in assessing the prognosis of colorectal carcinomas, paying specific attention to the evaluation of statistical analysis and multivariate procedures. Results Cell surface molecules have been identified on colorectal carcinoma cells whose expression appears to be related to malignant transformation, tumor progression, or patient prognosis. Among these cell surface molecules, various cell adhesion molecules, growth factor receptors, proteinases, and their receptors and inhibitors have been identified as potentially useful prognostic markers, Conclusions Although data exist on the prognostic values of certain cell surface markers, the use of multivariate analysis for the identification of valuable prognostic factors remains uncommon. Using reproducible and standardized multivariate analysis procedures, new tumor markers should be carefully examined for their biologic and prognostic relevance before being considered as potentially useful in the management of colorectal cancers.
引用
收藏
页码:11 / 24
页数:14
相关论文
共 174 条
[1]   Gelatinase B (MMP-9) expression and survival in colorectal cancer patients [J].
Abdalla, SA ;
Jeziorska, M ;
Schofield, P ;
Woolley, DE ;
Haboubi, NY .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1997, 12 (06) :342-343
[2]   COLORECTAL-CANCER AND THE INTEGRIN FAMILY OF CELL-ADHESION RECEPTORS - CURRENT STATUS AND FUTURE-DIRECTIONS [J].
AGREZ, MV ;
BATES, RC .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (14) :2166-2170
[3]  
*AM CANC SOC SURV, 1998, VIT STAT US 1997
[4]  
Asai S, 1994, Nihon Geka Gakkai Zasshi, V95, P753
[5]  
BATTISTELLI S, 1990, Bollettino Societa Italiana Biologia Sperimentale, V66, P985
[6]  
BEHRENS J, 1994, INVAS METAST, V14, P61
[7]  
BENTON LD, 1993, SURG GYNECOL OBSTET, V177, P311
[8]   Cytoskeletal and adhesion proteins as tumor suppressors [J].
BenZeev, A .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (01) :99-108
[9]   The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back [J].
Berghella, AM ;
Pellegrini, P ;
Del Beato, T ;
Marini, M ;
Tomei, E ;
Adorno, D ;
Casciani, CU .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 45 (05) :241-249
[10]  
BERGHELLA AM, 1994, CANCER IMMUNOL IMMUN, V38, P160, DOI 10.1007/BF01525636